Goldman Sachs Group set a €65.00 ($75.58) target price on Gerresheimer (ETR:GXI) in a research note released on Thursday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.
A number of other analysts have also commented on GXI. Hauck & Aufhaeuser set a €120.00 ($139.53) price target on shares of Hypoport and gave the stock a sell rating in a research note on Thursday, April 11th. Deutsche Bank reduced their price target on shares of from GBX 217 ($2.84) to GBX 175 ($2.29) and set a sell rating for the company in a research note on Monday, June 24th. JPMorgan Chase & Co. set a GBX 3,200 ($41.81) price target on shares of Diageo and gave the stock a neutral rating in a research note on Wednesday. HSBC reduced their price target on shares of WPP from GBX 1,000 ($13.07) to GBX 970 ($12.67) and set a hold rating for the company in a research note on Thursday, July 4th. Finally, Credit Suisse Group reiterated a hold rating on shares of FactSet Research Systems in a research note on Monday, July 8th. Three equities research analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company. Gerresheimer presently has a consensus rating of Hold and a consensus price target of €69.17 ($80.43).
Shares of GXI stock opened at €73.65 ($85.64) on Thursday. The business has a 50 day moving average of €65.08. Gerresheimer has a 52 week low of €51.10 ($59.42) and a 52 week high of €80.25 ($93.31). The company has a market capitalization of $2.31 billion and a price-to-earnings ratio of 12.90. The company has a debt-to-equity ratio of 68.19, a current ratio of 0.78 and a quick ratio of 0.51.
Gerresheimer Company Profile
Gerresheimer AG manufactures and sells specialty glass and plastic products primarily for the pharma and healthcare industry worldwide. It operates through three divisions; Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. The Plastics & Devices division offers drug delivery systems, including inhalers, pen systems, and injection systems; sterile and non-sterile prefillable syringe systems for the pharmaceutical and biotech industries; and disposables for various analysis systems that are used in laboratories and medical practices, quick tests for patients in medical practices or hospitals, skin-prick aids and lancets for diabetics, disposables and components for dialysis machines, and catheters and surgical devices.
Further Reading: Put Option
Receive News & Ratings for Gerresheimer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gerresheimer and related companies with MarketBeat.com's FREE daily email newsletter.